Bone-Targeted Exercise Strategies to Reduce Fracture Risk in Men
High-intensity progressive resistance and impact training is a well-tolerated program that may improve bone mineral density and physical function in older men.
Osteoporosis
Major Osteoporotic Fracture in Older Women Not Linked to Long-Term ICS Use
In older women, the risk for major osteoporotic fracture is not associated with long-term inhaled corticosteroid use and consequent respiratory diseases.
Consensus Recommendations for the Diagnosis and Treatment of Secondary Osteoporosis in Children
The Osteogenesis Imperfecta and Childhood Osteoporosis Working Group of the Spanish Society of Pediatric Rheumatology developed guidelines for the prevention, diagnosis, and treatment of secondary childhood osteoporosis.
Proton Pump Inhibitors Use and Osteoporotic Fracture Risk in Older Women
Treatment with proton pump inhibitors is associated with increased risk for osteoporotic fracture compared with the use of histamine-2 receptor antagonists.
Management of Glucocorticoid-Induced Osteoporosis: An Overview
A major adverse effect of glucocorticoid treatment is significant bone loss, which is most pronounced in the first 3 to 6 months of use.
Computer Learning Model Accurately Predicts Osteoporosis From Hand Radiographs
Researchers determined whether a computer learning model could classify hand radiographs with osteoporosis based on the second metacarpal cortical percentage.
Incidence of Osteoporosis Significantly Higher in IBD
Incidence of osteoporosis is significantly increased in patients with inflammatory bowel disease.
Assessing Cardiovascular and Skeletal Safety of Zoledronic Acid for Osteoporosis
Treatment with zoledronic acid may be associated with an increased risk for heart failure, fracture, and mortality compared with the use of oral bisphosphonates or no treatment.
Reduced Volumetric Bone Mineral Density in Hyperuricemia Among Patients With Psoriasis
Researchers assessed the effect of hyperuricemia with and without psoriasis on bone microstructure and volumetric bone mineral density.
Denosumab Improves BMD, Vertebral Fracture Risk in Postmenopausal Women With Diabetes
Denosumab increases bone mineral density and decreases vertebral fracture risk in postmenopausal women with osteoporosis and diabetes.
Next post in Bone Metabolism
